These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 31083442)

  • 41. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
    Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
    J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain capillaries in Alzheimer's disease.
    Baloyannis SJ
    Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease.
    Elali A; Rivest S
    Front Physiol; 2013; 4():45. PubMed ID: 23494712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia.
    Wang P; Velagapudi R; Kong C; Rodriguiz RM; Wetsel WC; Yang T; Berger M; Gelbard HA; Colton CA; Terrando N
    Alzheimers Dement; 2020 May; 16(5):734-749. PubMed ID: 32291962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
    Deane R; Zlokovic BV
    Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reconsidering the role of blood-brain barrier in Alzheimer's disease: From delivery to target.
    Sousa JA; Bernardes C; Bernardo-Castro S; Lino M; Albino I; Ferreira L; Brás J; Guerreiro R; Tábuas-Pereira M; Baldeiras I; Santana I; Sargento-Freitas J
    Front Aging Neurosci; 2023; 15():1102809. PubMed ID: 36875694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vascular factors in the pathogenesis of Alzheimer's disease].
    Lange-Asschenfeldt C
    Nervenarzt; 2013 Jun; 84(6):732-7. PubMed ID: 23695007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
    Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
    Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Constitutive NOS Production Is Modulated by Alzheimer's Disease Pathology Depending on APOE Genotype.
    Bonomi CG; Martorana A; Fiorelli D; Nuccetelli M; Placidi F; Mercuri NB; Motta C
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.
    He JT; Zhao X; Xu L; Mao CY
    J Alzheimers Dis; 2020; 73(1):39-58. PubMed ID: 31815697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease.
    Zhao M; Jiang XF; Zhang HQ; Sun JH; Pei H; Ma LN; Cao Y; Li H
    Ageing Res Rev; 2021 Dec; 72():101483. PubMed ID: 34610479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions between nanoparticles and pathological changes of vascular in Alzheimer's disease.
    Lei T; Yang Z; Li H; Qin M; Gao H
    Adv Drug Deliv Rev; 2024 Apr; 207():115219. PubMed ID: 38401847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.
    Nelson AR
    Front Aging Neurosci; 2022; 14():858429. PubMed ID: 35517047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
    Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
    Bi D; Wen L; Wu Z; Shen Y
    Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular dysfunction-The disregarded partner of Alzheimer's disease.
    Sweeney MD; Montagne A; Sagare AP; Nation DA; Schneider LS; Chui HC; Harrington MG; Pa J; Law M; Wang DJJ; Jacobs RE; Doubal FN; Ramirez J; Black SE; Nedergaard M; Benveniste H; Dichgans M; Iadecola C; Love S; Bath PM; Markus HS; Al-Shahi Salman R; Allan SM; Quinn TJ; Kalaria RN; Werring DJ; Carare RO; Touyz RM; Williams SCR; Moskowitz MA; Katusic ZS; Lutz SE; Lazarov O; Minshall RD; Rehman J; Davis TP; Wellington CL; González HM; Yuan C; Lockhart SN; Hughes TM; Chen CLH; Sachdev P; O'Brien JT; Skoog I; Pantoni L; Gustafson DR; Biessels GJ; Wallin A; Smith EE; Mok V; Wong A; Passmore P; Barkof F; Muller M; Breteler MMB; Román GC; Hamel E; Seshadri S; Gottesman RF; van Buchem MA; Arvanitakis Z; Schneider JA; Drewes LR; Hachinski V; Finch CE; Toga AW; Wardlaw JM; Zlokovic BV
    Alzheimers Dement; 2019 Jan; 15(1):158-167. PubMed ID: 30642436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.